This announcement is a separate document:
復星醫藥:2022年第二次臨時股東大會通告
FOSUN PHARMA: NOTICE OF 2022 SECOND EXTRAORDINARY GENERAL MEETING
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
10:05
Shanghai Electric Group and Mitsubishi Electric Corp. unsponsored ADR have initiated negotiations to update the joint venture contract.
Shanghai Electric Group-0.44%
10:05
Simcere pharma's new Polθ inhibitor SIM0508 has completed the world's first patient medication.
SIMCERE PHARMA+0.71%
10:04
Shanghai Stock Exchange: E Fund ChiNext ESG ETF, a central enterprise ESG open-end index fund, will be listed and traded on December 9, with the code 560810.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.